In HCC patients, CDK4 has been observed to be significantly expressed and linked to a number of advanced clinical characteristics (OS event, T-stage histologic grade, tumor status), implying that CDK4 needs additional clinical validation as a possible prognostic and diagnostic marker. Here, CDK4 is linked to neoplasm.